Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
Développer la qualité dans le champ sanitaire, social et médico-social
Logo
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. root
  2. SELADELPAR GILEAD (seladelpar lysine dihydraté)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • Établissements de santé
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

SELADELPAR GILEAD (seladelpar lysine dihydraté)

Medicine - Posted on Apr 17 2025
Active substance (DCI)
  • seladelpar
history (1)
  • 4/10/25

    SELADELPAR GILEAD (séladelpar lysine dihydraté) - Cholangite biliaire primitive

    Autorisation d’accès précoce refusée à la spécialité SELADELPAR GILEAD (séladelpar) dans l'indication « Traitement de la cho...
    icône flèche
Technical information
ATC code
  • A05AX07
Manufacturer
GILEAD SCIENCES SAS
Presentation

SELADELPAR GILEAD 10 mg, 
Flacon (PEHD), B/30 gélules (CIP : 34009 303 089 2 9)

All our publications
    Anemia and hemoglobinopathies Congenital, genetic and rare diseases Drug therapy Female genital diseases Genital cancers Metabolic diseases Paediatrics Urologic diseases - miscellaneous

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
snPVCrAxhwTZ3xxY